575 related articles for article (PubMed ID: 8809240)
21. Lamina propria and circulating interleukin-6 in newly diagnosed pediatric inflammatory bowel disease patients.
Brown KA; Back SJ; Ruchelli ED; Markowitz J; Mascarenhas M; Verma R; Piccoli DA; Baldassano RN
Am J Gastroenterol; 2002 Oct; 97(10):2603-8. PubMed ID: 12385446
[TBL] [Abstract][Full Text] [Related]
22. Risk of arterial thrombotic events in inflammatory bowel disease.
Ha C; Magowan S; Accortt NA; Chen J; Stone CD
Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
[TBL] [Abstract][Full Text] [Related]
23. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-4 inhibits the increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease.
Griga T; Hebler U; Voigt E; Tromm A; May B
Hepatogastroenterology; 2000; 47(36):1604-7. PubMed ID: 11149012
[TBL] [Abstract][Full Text] [Related]
25. [Significance of intestinal inflammation in the pathogenesis of spondylarthropathies].
Mielants H; Veys EM
Verh K Acad Geneeskd Belg; 1996; 58(2):93-116. PubMed ID: 8768479
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of inflammatory bowel disease in patients with airways disease.
Raj AA; Birring SS; Green R; Grant A; de Caestecker J; Pavord ID
Respir Med; 2008 May; 102(5):780-5. PubMed ID: 18321696
[TBL] [Abstract][Full Text] [Related]
27. Oral manifestations of inflammatory bowel disease: a review based on the observation of six cases.
Lourenço SV; Hussein TP; Bologna SB; Sipahi AM; Nico MM
J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):204-7. PubMed ID: 19552719
[TBL] [Abstract][Full Text] [Related]
28. The lung in inflammatory bowel disease.
Camus P; Piard F; Ashcroft T; Gal AA; Colby TV
Medicine (Baltimore); 1993 May; 72(3):151-83. PubMed ID: 8502168
[TBL] [Abstract][Full Text] [Related]
29. Inflammation and coagulation in inflammatory bowel disease: The clot thickens.
Danese S; Papa A; Saibeni S; Repici A; Malesci A; Vecchi M
Am J Gastroenterol; 2007 Jan; 102(1):174-86. PubMed ID: 17100967
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
Passarini B; Infusino SD; Barbieri E; Varotti E; Gionchetti P; Rizzello F; Morselli C; Tambasco R; Campieri M
Dermatology; 2007; 215(4):295-300. PubMed ID: 17911986
[TBL] [Abstract][Full Text] [Related]
31. An immunomodulation strategy targeted towards immunocompetent cells or cytokines in inflammatory bowel diseases (IBD).
Heresbach D; Sémana G; Gosselin M; Bretagne MG
Eur Cytokine Netw; 1999 Mar; 10(1):7-15. PubMed ID: 10210767
[TBL] [Abstract][Full Text] [Related]
32. Review article: skin complications associated with inflammatory bowel disease.
Tavarela Veloso F
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():50-3. PubMed ID: 15352894
[TBL] [Abstract][Full Text] [Related]
33. Clinical and experimental evidence of sympathetic neural dysfunction during inflammatory bowel disease.
Boissé L; Chisholm SP; Lukewich MK; Lomax AE
Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):1026-33. PubMed ID: 19566829
[TBL] [Abstract][Full Text] [Related]
34. Local thrombolysis: a newer approach to treating inflammatory bowel disease-related thromboembolism.
Tabibian JH; Roth BE
J Clin Gastroenterol; 2009; 43(5):391-8. PubMed ID: 19247203
[TBL] [Abstract][Full Text] [Related]
35. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
36. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
Cantor MJ; Nickerson P; Bernstein CN
Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
[TBL] [Abstract][Full Text] [Related]
37. Extradigestive manifestations of IBD in pediatrics.
Aloi M; Cucchiara S
Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():23-32. PubMed ID: 19530508
[TBL] [Abstract][Full Text] [Related]
38. Recent advances in biological therapy for inflammatory bowel disease.
Kurtovic J; Segal I
Trop Gastroenterol; 2004; 25(1):9-14. PubMed ID: 15303463
[TBL] [Abstract][Full Text] [Related]
39. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease.
Hibi T; Inoue N; Ogata H; Naganuma M
J Gastroenterol; 2003 Mar; 38 Suppl 15():36-42. PubMed ID: 12698869
[TBL] [Abstract][Full Text] [Related]
40. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
Nakase H; Okazaki K; Tabata Y; Chiba T
J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
